Scientific Misconduct

[Sharoni] Shafir and [Donald] Kennedy are right to be concerned about the state of scientific misconduct--both real and perceived--in this country (Opinion, The Scientist, 12[13]:9, June 22, 1998), but they fall into the typical traps awaiting most researchers critiquing science journalism. In the first place, they fault news media coverage of the Acadia study (J.P. Swazey et al., American Scientist, 81:542-53, 1993) as suggesting that "such misconduct is common." My perception of the overall

Written byEarle Holland
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

[Sharoni] Shafir and [Donald] Kennedy are right to be concerned about the state of scientific misconduct--both real and perceived--in this country (Opinion, The Scientist, 12[13]:9, June 22, 1998), but they fall into the typical traps awaiting most researchers critiquing science journalism.

In the first place, they fault news media coverage of the Acadia study (J.P. Swazey et al., American Scientist, 81:542-53, 1993) as suggesting that "such misconduct is common." My perception of the overall reporting of that research was that incidents of actual misconduct, or activities that seem inappropriate, were more common than had been previously thought. The difference between the two statements is important since to date, no one really knows how prevalent scientific misconduct actually is.

Secondly, they fault reporters for excluding concerns over the possible role self- selection bias might have played in the study. Ben Bradlee, former editor of the Washington Post and a science writer ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies